Who is sponsoring NCT01193504?

NCT01193504 is sponsored by Innovative Medical.

What condition does NCT01193504 study?

NCT01193504 studies Pseudophakia, Cataract Surgery.

What drugs are being tested in NCT01193504?

Interventions: Pred Forte, Lotemax.

What is the status of NCT01193504?

NCT01193504 is currently UNKNOWN.

Last reviewed 2012-06-13 · How we verify

Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

NCT01193504 Phase 4 UNKNOWN

The purpose of this study is to determine if Lotemax eye drops are at least as effective as Pred Forte eye drops, which are the standard of care after cataract surgery.

Details

Lead sponsor	Innovative Medical
Phase	Phase 4
Status	UNKNOWN
Enrolment	100
Start date	2010-09
Completion	2012-10

Conditions

Pseudophakia
Cataract Surgery

Interventions

Pred Forte
Lotemax

Primary outcomes

Prevention Of Retinal Thickening — 1 Year
* OCT (optical coherence tomography) with macular thickening * Incidence of CME ( cystoids macular edema) * BCVA (best corrected visual acuity) * UCVA (uncorrected visual acuity) * Central corneal thickness

Countries

United States